Abstract:Purpose: To quantify interfractional anatomical variations and their dosimetric impact during the course of fractionated proton therapy (PT) of prostate cancer and to assess the robustness of the current treatment planning techniques.Methods: Simulation and daily in-room CT scans from ten prostate carcinoma patients were analyzed. PT treatment plans (78 Gy in 39 fractions of 2 Gy) were created on the simulation CT, delivering 25 fractions to PTV1 (expanded from prostate and seminal vesicles), followed by 14 boost fractions to PTV2 (expanded from prostate). Plans were subsequently applied to daily CT, with beams aligned to the prostate center in the sagittal plane. For five patients having a sufficiently large daily imaging volume, structure contours were manually drawn, and plans were evaluated for all CT sets. For the other five patients, the plans were evaluated for six selected fractions. The daily CT was matched to the simulation CT through deformable registration. The registration accuracy was validated for each fraction, and the three patients with a large number of accurately registered fractions were used for dose accumulation.Results: In individual fractions, the coverage of the prostate, seminal vesicles, and PTV1 was generally maintained at the corresponding prescription dose. For PTV2, the volume covered by the fractional prescription dose of 2 Gy (i.e., V2) was, on average, reduced by less than 3% compared to the simulation plan. Among the 225 (39 x 5 + 6 x 5) fractions examined, 15 showed a V2 reduction larger than 5%, of which ten were caused by a large variation in rectal gas, and five were due to a prostate shift in the craniocaudal direction. The fractional dose to the anterior rectal wall was found to increase for one patient who had large rectal gas volume in 25 of the 39 fractions, and another who experienced significant prostate volume reduction during the treatment. The fractional bladder dose generally increased with decreasing fullness. In the total accumulated dose for the three patients after excluding a few fractions with inaccurate registration due to a large amount of rectal gas (a condition inconsistent with RTOG protocol), 98.5%, 96.6%, and 98.2% of the PTV2 received the prescription dose of 78 Gy. The V75 and V70 of the anterior rectal wall and bladder both remained within tolerance.Conclusions: The results confirm that the PT planning techniques and dose constraints used at our institution ensure that target coverage to the prescription dose is maintained in the presence of interfractional anatomical variations. Dose coverage in individual fractions can be compromised, and normal tissue dose increased, due to deviations in the bladder and rectal volume compared to the simulation plans or progressive changes in the prostate volume during the treatment. Deviations from the plan can be reduced with efforts aimed at maintaining consistent daily patient anatomy. (C) 2011 American Association of Physicists in Medicine. [DOI: 10.1118/1.3604152]

Evaluation of Transrectal Ultrasound-Based Dosimetry for Brachytherapy of Prostate Cancer: a Single-Center Experience

Establishment and Short-Term Efficacy of Ultrasound-Guided 125I Seed Interstitial Brachytherapy for Prostatic Carcinoma

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

The Dosimetry Evaluation of 3D Printing Non-Coplanar Template-Assisted CT-guided 125I Seed Stereotactic Ablation Brachytherapy for Pelvic Recurrent Rectal Cancer after External Beam Radiotherapy.

MRI Prostate Volumetry As a Surrogate for Transrectal Ultrasound Volumetry in Estimating Iodine – 125 Seeds in Brachytherapy: Conventional Prolate Ellipsoid Volume Algorithm Versus a Modified Bullet-Shape Volume Algorithm

Clinical Application of Transperineal ~(125)I-Seed Implantation Guided by Ultrasonography in Prostate Cancer

SU‐E‐T‐12: A Comparative Dosimetric Study of Pre and Post Prostate Iodine‐125 Permanent Seed Implants

Dosimetry Verification of 125 I Seeds Implantation With Three-Dimensional Printing Noncoplanar Templates and CT Guidance for Paravertebral/Retroperitoneal Malignant Tumors.

The Accuracy and Safety of CT-guided Iodine-125 Seed Implantation Assisted by 3D Non-Coplanar Template for Retroperitoneal Recurrent Carcinoma.

Transperineal ultrasound guided ~(125)I seed implantation combined with endocrinotherapy for stage T_1-T_2 prostate cancer

Dosimetry Verification of 125I Seeds Implantation With Three-Dimensional Printing Noncoplanar Templates and CT Guidance for Paravertebral/Retroperitoneal Malignant Tumors

Accuracy and Dosimetric Parameters Comparison of 3D-Printed Non-Coplanar Template-Assisted Computed Tomography-Guided Iodine-125 Seed Ablative Brachytherapy in Pelvic Lateral Recurrence of Gynecological Carcinomas

Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience

Image Guidance Improves Gain Ratio in Radioactive Seeds Brachytherapy

Transrectal ultrasound for intraoperative interstitial needle guidance in cervical cancer brachytherapy

Dosimetric comparison of computed tomography-guided iodine-125 seed implantation assisted with and without three-dimensional printing non-coplanar template in locally recurrent rectal cancer: a propensity score matching study

Expert Consensus on Computed Tomography-Assisted Three-Dimensional-printed Coplanar Template Guidance for Interstitial Permanent Radioactive125i Seed Implantation Therapy

Combination of Transrectal 125 I Seeds Implantation Brachytherapy and Intermittent Hormonal Therapy for Locally Advanced Prostate Cancer

Transperineal Iodine- 125 Seed Implantation Guided by Transrectal Ultrasonography in Prostate Cancer

Dosimetric Analysis of 3D-Printed Coplanar Template-Assisted and CT-guided 125I Seed Implantation for the Treatment of Malignant Tumors

TH‐AB‐BRA‐01: Biologically Based Prostate Cancer Treatment Planning with Combined Brachytherapy and External Beam Radiotherapy